Identification of a microglia phenotype supportive of remyelination

GLIA

Volumn 60, Issue 2, 2012, Pages 306-321

  Olah, Marta ^a   Amor, Sandra ^b,c   Brouwer, Nieske ^a   Vinet, Jonathan ^a   Eggen, Bart ^a   Biber, Knut ^a,d   Boddeke, Hendrikus W G M ^a  

^a UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

^b VU UNIVERSITY MEDICAL CENTER   (Netherlands)

^c QUEEN MARY UNIVERSITY OF LONDON   (United Kingdom)

^d UNIVERSITY OF FREIBURG   (Germany)

Author keywords

Microglia phenotype; Preactive lesions; Remyelination

Indexed keywords

CHEMOKINE; CUPRIZONE; CYTOKINE; MYELIN;

ANIMAL EXPERIMENT; ANIMAL TISSUE; APOPTOSIS; ARTICLE; CONTROLLED STUDY; CORPUS CALLOSUM; CYTOKINE PRODUCTION; DEMYELINATION; DIETARY INTAKE; GENE EXPRESSION; GENETIC ANALYSIS; MALE; MICROGLIA; MOUSE; NERVE REGENERATION; NONHUMAN; PHAGOCYTOSIS; PHENOTYPE; PRIORITY JOURNAL; REMYELINIZATION;

ANIMALS; DEMYELINATING DISEASES; DISEASE MODELS, ANIMAL; MALE; MICE; MICE, INBRED C57BL; MICROGLIA; MYELIN SHEATH; NERVE FIBERS, MYELINATED; NERVE REGENERATION; PHENOTYPE;

EID: 83055184202     PISSN: 08941491     EISSN: 10981136     Source Type: Journal    
DOI: 10.1002/glia.21266     Document Type: Article

References (73)

1. Almolda B, González B, Castellano B. 2010. Activated microglial cells acquire an immature dendritic cell phenotype and may terminate the immune response in an acute model of EAE. J Neuroimmunol 223: 39-54.
2. Arnett HA, Hellendall RP, Matsushima GK, Suzuki K, Laubach VE, Sherman P, Ting JP. 2002. The protective role of nitric oxide in a neurotoxicant-induced demyelinating model. J Immunol 168: 427-433.
3. Arnett HA, Mason J, Marino M, Suzuki K, Matsushima GK, Ting JP. 2001. TNF α promotes proliferation of oligodendrocyte progenitors and remyelination. Nat Neurosci 4: 1116-1122.
4. Arnett HA, Wang Y, Matsushima GK, Suzuki K, Ting JP. 2003. Functional genomic analysis of remyelination reveals importance of inflammation in oligodendrocyte regeneration. J Neurosci 23: 9824-9832.
5. Ashcroft GS, Lei K, Jin W, Longenecker G, Kulkarni AB, Greenwell-Wild T, Hale-Donze H, McGrady G, Song XY, Wahl SM. 2000. Secretory leukocyte protease inhibitor mediates non-redundant functions necessary for normal wound healing. Nat Med 6: 1147-1153.
6. Bakker DA, Ludwin SK. 1987. Blood-brain barrier permeability during cuprizone-induced demyelination. Implications for the pathogenesis of immune-mediated demyelinating diseases. J Neurol Sci 78: 125-137.
7. Baumann N, Pham-Dinh D. 2001. Biology of oligodendrocyte and myelin in the mammalian central nervous system. Physiol Rev 81: 871-927.
8. Bechmann I, Peter S, Beyer M, Gimsa U, Nitsch R. 2001. Presence of B7-2 (CD86) and lack of B7-1 (CD80) on myelin phagocytosing MHC-II-positive rat microglia is associated with nondestructive immunity in vivo. FASEB J 15: 1086-1088.
9. Bieber AJ, Kerr S, Rodriguez M. 2003. Efficient central nervous system remyelination requires T cells. Ann Neurol 53: 680-684.
10. Blakemore WF, Franklin RJ. 2008. Remyelination in experimental models of toxin-induced demyelination. Curr Top Microbiol Immunol 318: 193-212.
11. Blakemore WF, Keirstead HS. 1999. The origin of remyelinating cells in the central nervous system. J Neuroimmunol 98: 69-76.
12. Boven LA, Van MM, Van ZM, Wierenga-Wolf A, Hintzen RQ, Boot RG, Aerts JM, Amor S, Nieuwenhuis EE, Laman JD. 2006. Myelin-laden macrophages are anti-inflammatory, consistent with foam cells in multiple sclerosis. Brain 129: 517-526.
13. Bradl M, Lassmann H. 2010. Oligodendrocytes: Biology and pathology. Acta Neuropathol 119: 37-53.
14. Brosnan CF, Bornstein MB, Bloom BR. 1981. The effects of macrophage depletion on the clinical and pathologic expression of experimental allergic encephalomyelitis. J Immunol 126: 614-620.
15. Carson MJ. 2002. Microglia as liaisons between the immune and central nervous systems: Functional implications for multiple sclerosis. Glia 40: 218-231.
16. Chesik D, De Keyser J, Wilczak N. 2008. Insulin-like growth factor system regulates oligodendroglial cell behavior: Therapeutic potential in CNS. J Mol Neurosci 35: 81-90.
17. Diemel LT, Jackson SJ, Cuzner ML. 2003. Role for TGF-β1, FGF-2 and PDGF-AA in a myelination of CNS aggregate cultures enriched with macrophages. J Neurosci Res 74: 858-867.
18. Doumas S, Kolokotronis A, Stefanopoulos P. 2005. Anti-inflammatory and antimicrobial roles of secretory leukocyte protease inhibitor. Infect Immun 73: 1271-1274.
19. Duncan DS, Miller SD. 2011. CNS expression of B7-H1 regulates pro-inflammatory cytokine production and alters severity of Theiler's virus-induced demyelinating disease. PLoS One 6: e18548.
20. Ferrari CC, Depino AM, Prada F, Muraro N, Campbell S, Podhajcer O, Perry VH, Anthony DC, Pitossi FJ. 2004. Reversible demyelination, blood-brain barrier breakdown, and pronounced neutrophil recruitment induced by chronic IL-1 expression in the brain. Am J Pathol 165: 1827-1837.
21. Foote AK, Blakemore WF. 2005. Inflammation stimulates remyelination in areas of chronic demyelination. Brain 128: 528-539.
22. Franklin RJ. 2002. Why does remyelination fail in multiple sclerosis? Nat Rev Neurosci 3: 705-714.
23. Franklin RJ, Ffrench-Constant C. 2008. Remyelination in the CNS: From biology to therapy. Nat Rev Neurosci 9: 839-855.
24. Frost EE, Nielsen JA, Le TQ, Armstrong RC. 2003. PDGF and FGF2 regulate oligodendrocyte progenitor responses to demyelination. J Neurobiol 54: 457-472.
25. Fujimoto Y, Tedder TF. 2006. CD83: A regulatory molecule of the immune system with great potential for therapeutic application. J Med Dent Sci 53: 85-91.
26. Gudi V, Moharregh-Khiabani D, Skripuletz T, Koutsoudaki PN, Kotsiari A, Skuljec J, Trebst C, Stangel M. 2009. Regional differences between grey and white matter in cuprizone induced demyelination. Brain Res 1283: 127-138.
27. Gudi V, Skuljec J, Yildiz O, Frichert K, Skripuletz T, Moharregh-Khiabani D, Voss E, Wissel K, Wolter S, Stangel M. 2011. Spatial and temporal profiles of growth factor expression during CNS demyelination reveal the dynamics of repair priming. PLoS One 6: e22623.
28. Hanisch UK, Kettenmann H. 2007. Microglia: Active sensor and versatile effector cells in the normal and pathologic brain. Nat Neurosci 10: 1387-1394.
29. Hinks GL, Franklin RJ. 1999. Distinctive patterns of PDGF-A, FGF-2, IGF-I, and TGF-β1 gene expression during remyelination of experimentally-induced spinal cord demyelination. Mol Cell Neurosci 14: 153-168.
30. Hohlfeld R, Kerschensteiner M, Meinl E. 2007. Dual role of inflammation in CNS disease. Neurology 68: S58-S63.
31. Hsieh J, Aimone JB, Kaspar BK, Kuwabara T, Nakashima K, Gage FH. 2004. IGF-I instructs multipotent adult neural progenitor cells to become oligodendrocytes. J Cell Biol 164: 111-122.
32. Huitinga I, van RN, de Groot CJ, Uitdehaag BM, Dijkstra CD. 1990. Suppression of experimental allergic encephalomyelitis in Lewis rats after elimination of macrophages. J Exp Med 172: 1025-1033.
33. Jurevics H, Bouldin TW, Toews AD, Morell P. 1998. Regenerating sciatic nerve does not utilize circulating cholesterol. Neurochem Res 23: 401-406.
34. Jurevics H, Largent C, Hostettler J, Sammond DW, Matsushima GK, Kleindienst A, Toews AD, Morell P. 2002. Alterations in metabolism and gene expression in brain regions during cuprizone-induced demyelination and remyelination. J Neurochem 82: 126-136.
35. Keir ME, Butte MJ, Freeman GJ, Sharpe AH. 2008. PD-1 and its ligands in tolerance and immunity. Annu Rev Immunol 26: 677-704.
36. Kim HM, Hwang DH, Lee JE, Kim SU, Kim BG. 2009. Ex vivo VEGF delivery by neural stem cells enhances proliferation of glial progenitors, angiogenesis, and tissue sparing after spinal cord injury. PLoS One 4: e4987.
37. Kondo A, Nakano T, Suzuki K. 1987. Blood-brain barrier permeability to horseradish peroxidase in twitcher and cuprizone-intoxicated mice. Brain Res 425: 186-190.
38. Kotter MR, Li WW, Zhao C, Franklin RJ. 2006. Myelin impairs CNS remyelination by inhibiting oligodendrocyte precursor cell differentiation. J Neurosci 26: 328-332.
39. Kotter MR, Zhao C, van Rooijen N, Franklin RJ. 2005. Macrophage-depletion induced impairment of experimental CNS remyelination is associated with a reduced oligodendrocyte progenitor cell response and altered growth factor expression. Neurobiol Dis 18: 166-175.
40. Lassmann H. 2008. Mechanisms of inflammation induced tissue injury in multiple sclerosis. J Neurol Sci 274: 45-47.
41. Li WW, Setzu A, Zhao C, Franklin RJ. 2005. Minocycline-mediated inhibition of microglia activation impairs oligodendrocyte progenitor cell responses and remyelination in a non-immune model of demyelination. J Neuroimmunol 158: 58-66.
42. Liñares D, Taconis M, Maña P, Correcha M, Fordham S, Staykova M, Willenborg DO. 2006. Neuronal nitric oxide synthase plays a key role in CNS demyelination. J Neurosci 26: 12672-12681.
43. Ma J, Tanaka KF, Shimizu T, Bernard CC, Kakita A, Takahashi H, Pfeiffer SE, Ikenaka K. 2011. Microglial cystatin F expression is a sensitive indicator for ongoing demyelination with concurrent remyelination. J Neurosci Res 89: 639-649.
44. Magnus T, Schreiner B, Korn T, Jack C, Guo H, Antel J, Ifergan I, Chen L, Bischof F, Bar-Or A, Wiendl H. 2005. Microglial expression of the B7 family member B7 homolog 1 confers strong immune inhibition: Implications for immune responses and autoimmunity in the CNS. J Neurosci 25: 2537-2546.
45. Mason JL, Suzuki K, Chaplin DD, Matsushima GK. 2001. Interleukin-1β promotes repair of the CNS. J Neurosci 21: 7046-7052.
46. Matsushima GK, Morell P. 2002. The neurotoxicant, cuprizone, as a model to study demyelination and remyelination in the central nervous system. Brain Pathol 11: 107-116.
47. McMahon EJ, Suzuki K, Matsushima GK. 2002. Peripheral macrophage recruitment in cuprizone-induced CNS demyelination despite an intact blood-brain barrier. J Neuroimmunol 130: 32-45.
48. Morell P, Barrett CV, Mason JL, Toews AD, Hostettler JD, Knapp GW, Matsushima GK. 1998. Gene expression in brain during cuprizone-induced demyelination and remyelination. Mol Cell Neurosci 12: 220-227.
49. Napoli I, Neumann H. 2009. Microglial clearance function in health and disease. Neuroscience 158: 1030-1038.
50. Napoli I, Neumann H. 2010. Protective effects of microglia in multiple sclerosis. Exp Neurol 225: 24-28.
51. Nataf S. 2009. Neuroinflammation responses and neurodegeneration in multiple sclerosis. Rev Neurol (Paris) 165: 1023-1028.
52. Odaka C, Mizuochi T, Yang J, Ding A. 2003. Murine macrophages produce secretory leukocyte protease inhibitor during clearance of apoptotic cells: Implications for resolution of the inflammatory response. J Immunol 171: 1507-1514.
53. Ortler S, Leder C, Mittelbronn M, Zozulya AL, Knolle PA, Chen L, Kroner A, Wiendl H. 2008. B7-H1 restricts neuroantigen-specific T cell responses and confines inflammatory CNS damage: Implications for the lesion pathogenesis of multiple sclerosis. Eur J Immunol 38: 1734-1744.
54. Patani R, Balaratnam M, Vora A, Reynolds R. 2007. Remyelination can be extensive in multiple sclerosis despite a long disease course. Neuropathol Appl Neurobiol 33: 277-287.
55. Patrikios P, Stadelmann C, Kutzelnigg A, Rauschka H, Schmidbauer M, Laursen H, Sorensen PS, Bruck W, Lucchinetti C, Lassmann H. 2006. Remyelination is extensive in a subset of multiple sclerosis patients. Brain 129: 3165-3172.
56. Redford EJ, Hall SM, Smith KJ. 1995. Vascular changes and demyelination induced by the intraneural injection of tumour necrosis factor. Brain 118(Part 4): 869-878.
57. Reichert F, Rotshenker S. 1999. Galectin-3/MAC-2 in experimental allergic encephalomyelitis. Exp Neurol 160: 508-514.
58. Remington LT, Babcock AA, Zehntner SP, Owens T. 2007. Microglial recruitment, activation, and proliferation in response to primary demyelination. Am J Pathol 170: 1713-1724.
59. Rivest S. 2009. Regulation of innate immune responses in the brain. Nat Rev Immunol 9: 429-439.
60. Rodriguez M. 2007. Effectors of demyelination and remyelination in the CNS: Implications for multiple sclerosis. Brain Pathol 17: 219-229.
61. Rotshenker S, Reichert F, Gitik M, Haklai R, Elad-Sfadia G, Kloog Y. 2008. Galectin-3/MAC-2, Ras and PI3K activate complement receptor-3 and scavenger receptor-AI/II mediated myelin phagocytosis in microglia. Glia 56: 1607-1613.
62. Savill J, Dransfield I, Gregory C, Haslett C. 2002. A blast from the past: Clearance of apoptotic cells regulates immune responses. Nat Rev Immunol 2: 965-975.
63. Selvaraju R, Bernasconi L, Losberger C, Graber P, Kadi L, Avellana-Adalid V, Picard-Riera N, Van Evercooren AB, Cirillo R, Kosco-Vilbois M, Feger G, Papoian R, Boschert U. 2004. Osteopontin is upregulated during in vivo demyelination and remyelination and enhances myelin formation in vitro. Mol Cell Neurosci 25: 707-721.
64. Setzu A, Lathia JD, Zhao C, Wells K, Rao MS, Ffrench-Constant C, Franklin RJ. 2006. Inflammation stimulates myelination by transplanted oligodendrocyte precursor cells. Glia 54: 297-303.
65. Shah VB, Williams DL, Keshvara L. 2009. β-Glucan attenuates TLR2- and TLR4-mediated cytokine production by microglia. Neurosci Lett 458: 111-115.
66. Sharief MK. 1998. Cytokines in multiple sclerosis: Pro-inflammation or pro-remyelination? Mult Scler 4: 169-173.
67. Skuljec J, Gudi V, Ulrich R, Frichert K, Yildiz O, Pul R, Voss EV, Wissel K, Baumgärtner W, Stangel M. 2011. Matrix metalloproteinases and their tissue inhibitors in cuprizone-induced demyelination and remyelination of brain white and gray matter. J Neuropathol Exp Neurol 70: 758-769.
68. Starossom SC, Imitola J, Wang Y, Cao L, Khoury SJ. 2011. Subventricular zone microglia transcriptional networks. Brain Behav Immun 25: 991-999.
69. Ulrich R, Baumgärtner W, Gerhauser I, Seeliger F, Haist V, Deschl U, Alldinger S. 2006. MMP-12, MMP-3, and TIMP-1 are markedly upregulated in chronic demyelinating Theiler murine encephalomyelitis. J Neuropathol Exp Neurol 65: 783-793.
70. Van der Valk P, De Groot CJ. 2000. Staging of multiple sclerosis (MS) lesions: Pathology of the time frame of MS. Neuropathol Appl Neurobiol 26: 2-10.
71. Vela JM, Molina-Holgado E, Arévalo-Martin A, Almazan G, Guaza C. 2002. Interleukin-1 regulates proliferation and differentiation of oligodendrocyte progenitor cells. Mol Cell Neurosci 20: 489-502.
72. Viglietta V, Khoury SJ. 2007. Modulating co-stimulation. Neurotherapeutics 4: 666-675.
73. Woodruff RH, Fruttiger M, Richardson WD, Franklin RJ. 2004. Platelet-derived growth factor regulates oligodendrocyte progenitor numbers in adult CNS and their response following CNS demyelination. Mol Cell Neurosci 25: 252-262.